“…Because of the rarity of T-LGL leukemia, very few prospective clinical trials have been reported, and current treatment strategies are based on anecdotal case reports and small retrospective studies. In previous reports, treatment with immunomodulation, corticosteroids, low-dose methotrexate, cyclophosphamide, and cyclosporine A with or without purine analogues are all described [2,[9][10][11][12][13][14][15][16][17][18][19][20][21][22].…”